These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6656764

  • 41. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A, Wright JA.
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [Abstract] [Full Text] [Related]

  • 42. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells.
    Asano K, Sakamoto H, Sasaki H, Ochiya T, Yoshida T, Ohishi Y, Machida T, Kakizoe T, Sugimura T, Terada M.
    Biochem Biophys Res Commun; 1995 Dec 26; 217(3):1169-76. PubMed ID: 8554573
    [Abstract] [Full Text] [Related]

  • 43. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells.
    Smith KA, Gorman PA, Stark MB, Groves RP, Stark GR.
    Cell; 1990 Dec 21; 63(6):1219-27. PubMed ID: 1979757
    [Abstract] [Full Text] [Related]

  • 44. Structure of four amplified DNA novel joints.
    Legouy E, Fossar N, Lhomond G, Brison O.
    Somat Cell Mol Genet; 1989 Jul 21; 15(4):309-20. PubMed ID: 2569766
    [Abstract] [Full Text] [Related]

  • 45. Identification and localization of DNA alteration in Chinese hamster ovary cell mutants (Urd-) defective in the first three enzymes of de novo pyrimidine synthesis.
    Patterson D, Vannais DB, Niswander LA, Davidson JN.
    Somat Cell Mol Genet; 1985 Jul 21; 11(4):379-90. PubMed ID: 2992101
    [Abstract] [Full Text] [Related]

  • 46. Structural organization and expression of amplified chromosomal sequences, which include the rudimentary gene, in cultured Drosophila cells resistant to N-(phosphonacetyl)-L-aspartate.
    Laval M, Azou Y, Miassod R.
    Mol Gen Genet; 1989 Dec 21; 220(1):102-12. PubMed ID: 2481806
    [Abstract] [Full Text] [Related]

  • 47. Chromosome rearrangements associated with CAD gene amplification. Experiments with cell hybrids.
    Viaggi S, Nüsse M, Ottaggio L, Bonatti S.
    Mutat Res; 1992 Jan 21; 265(1):9-21. PubMed ID: 1370246
    [Abstract] [Full Text] [Related]

  • 48. Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
    Huang A, Jin H, Wright JA.
    Cancer Res; 1995 Apr 15; 55(8):1758-62. PubMed ID: 7712485
    [Abstract] [Full Text] [Related]

  • 49. Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.
    Baillon J, Guichard M, Malaise EP, Hervé G.
    Cancer Res; 1983 May 15; 43(5):2277-82. PubMed ID: 6831451
    [Abstract] [Full Text] [Related]

  • 50. Hamster cells with increased rates of DNA amplification, a new phenotype.
    Giulotto E, Knights C, Stark GR.
    Cell; 1987 Mar 13; 48(5):837-45. PubMed ID: 3815526
    [Abstract] [Full Text] [Related]

  • 51. Loss of chromosomal integrity in neoplasia.
    Tlsty TD, Jonczyk P, White A, Sage M, Hall I, Schaefer D, Briot A, Livanos E, Roelofs H, Poulose B.
    Cold Spring Harb Symp Quant Biol; 1993 Mar 13; 58():645-54. PubMed ID: 7956081
    [No Abstract] [Full Text] [Related]

  • 52. CAD overexpression in mammalian cells.
    Qiu Y, Davidson JN.
    Adv Exp Med Biol; 1998 Mar 13; 431():481-5. PubMed ID: 9598115
    [No Abstract] [Full Text] [Related]

  • 53. N-(Phosphonacetyl)-L-aspartate-resistant hamster cells overaccumulate a single mRNA coding for the multifunctional protein that catalyzes the first steps of UMP synthesis.
    Padgett RA, Wahl GM, Coleman PF, Stark GR.
    J Biol Chem; 1979 Feb 10; 254(3):974-80. PubMed ID: 762107
    [Abstract] [Full Text] [Related]

  • 54. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW, Jayaram HN, Cooney DA.
    Adv Enzyme Regul; 1982 Feb 10; 20():57-73. PubMed ID: 7113804
    [Abstract] [Full Text] [Related]

  • 55. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW, Mutter G, Hankerson JG, Reck LJ, Harley C, Han N, Ardalan B, Cysyk RL, Johnson RK, Jayaram HN, Cooney DA.
    Cancer Res; 1981 Mar 10; 41(3):894-904. PubMed ID: 7459875
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Unstable and stable CAD gene amplification: importance of flanking sequences and nuclear environment in gene amplification.
    Meinkoth J, Killary AM, Fournier RE, Wahl GM.
    Mol Cell Biol; 1987 Apr 10; 7(4):1415-24. PubMed ID: 3600632
    [Abstract] [Full Text] [Related]

  • 60. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
    Moore EC, Friedman J, Valdivieso M, Plunkett W, Marti JR, Russ J, Loo TL.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3317-21. PubMed ID: 7150358
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.